IDH (Integrated Diagnostics Holdings) is a woman-led, fully integrated medical-diagnostics company operating in Egypt, Jordan, Nigeria, Sudan and Saudi Arabia. Through Egyptian brands such as Al Borg and Al Mokhtabar it runs over 600 branches, widening access to testing efficiently via a 'hub-and-spoke' model. It offers about 3,000 pathology tests—immunology, microbiology, hematology, endocrinology, molecular biology, genetics and more—under international accreditations, building trust through a record of quality and safety. It kept expanding in 2025 and plans about 200 new branches in 2026.
B
NARRATIVE VALUE
Certainty
●●○ medium
●●○ medium
ABCDEFG
There is no confirmed −; independently verified + decide the position (B). No unreachable strike-through.= non-additive meter
As of: 2026-Q3Status: ActiveCeiling reason: No confirmed −
History2026-Q3BHistory grows each quarter
Integrated Diagnostics Holdings (IDH): Access to trusted testing across MENA. The letter is B; certainty is medium. Unconfirmed concerns are placed under “Watching.” (As of 2026-Q3; estimate based on public information.)
Main narrative
One person’s story (N1)
+ A single story
People across MENA who found it hard to reach trusted clinical testing. Through IDH's hub-and-spoke network, they can access about 3,000 tests under international accreditation. The benefit appears as a collective: it runs over 600 branches in Egypt and elsewhere and plans about 200 new branches in 2026.
Source nature: IDH / Actis / P1 First-party / independent (investor). Positive effects are not used to offset negatives.
Positive / negative effects
+ effects
- Offering about 3,000 pathology tests—immunology, microbiology, hematology, molecular biology, genetics—under international accreditation.P1 First-party / Integrated Diagnostics Holdings
− effects (confirmed)
- No confirmed −.
Watching (unconfirmed; not counted in the assessment)
- A listed, for-profit healthcare company (aims include revenue and shareholder returns)
- a tilt toward premium/out-of-pocket diagnostics and access equity for the poorest
- diagnostics-access outcomes are partly self-reported.
Looking ahead (not included in the assessment)
- Access equity for the poorest; links with public health; digital integration; maintaining quality/accreditation while expanding regionally.
A second look
The plus is access to trusted clinical testing and diagnostics for people across MENA (People), backed by 600+ branches, 3,000 tests, international accreditation, and woman-led management. But it is a listed, for-profit healthcare company whose aims include revenue and shareholder returns, and a tilt toward premium/out-of-pocket diagnostics raises the question of access equity for the poorest. Recognizing the genuine diagnostics-access plus but noting the for-profit model, B/medium.
Sources
+N1IDH / Actis｜IDH company profile｜2025｜🔗
+ effectIntegrated Diagnostics Holdings｜IDH investor relations｜2025｜🔗
How to read this assessment
A Independently verified +, with no confirmed −
B Leans +, with independent backing
C Mixed. A confirmed − sets the ceiling, or much is unverified
D A serious confirmed − sets the ceiling
E A serious − reaches the core of the organization
F Serious and systemic, with little redeeming +
G Only extreme cases
Out of scope An entity whose core purpose is illegal
On hold Independent evidence is scarce on both + and −
- Reachable upper bound (ceiling): a confirmed − sets the ceiling, and independently verified + decide the position within it. + do not cancel out −.
- The weight of evidence is not symmetric: only confirmed − are counted; the volume of disputes or allegations goes under “Watching.” + are counted from independent evidence, while an organization’s own PR is treated as “reference.”
- Size is not value: scale is not used in the assessment. Matters that stay within money or competition—investors, shareholders, sanctions, trade secrets—are also excluded.
- The letter (assessment) and certainty (how reliable the information is) are separate axes.
This is a translation; the Japanese version is authoritative. The assessments here are generated automatically by AI based on published criteria. The operator does not alter individual results. Because they are AI-generated they may contain errors, and they are opinion and commentary, not statements of fact. Where evidence is insufficient, the entry is marked “On hold.” Requests for correction are accepted via the form.
Terms: Narrative Value = an assessment (A–G) of the distance between the narrative an organization tells and its reality / Ceiling meter = a visualization of the reachable upper bound / Watching = unconfirmed matters not counted / Protected stakeholders = people, animals, nature, and future generations. | Generated by: AI | As of: 2026-Q3 | Back to top